CLINICAL_TRIALS
trial_result
· 2021-04-08
Clinical Trial Update: Extension Study of EC145 (Vintafolide) for Subjects Enrolled in a Previous Study With EC145 (MK-8109-010) [Phase 2]
Summary
Phase 2 extension study update for EC145 (Vintafolide) in subjects from a previous MK-8109-010 study; study status is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Endocyte | Conditions: Solid Tumors | Phase 2 | Status: COMPLETED